Literature DB >> 12371966

P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.

Sylvia Rost1, Christoph Daniel, Eckhard Schulze-Lohoff, Hans G Bäumert, Günter Lambrecht, Christian Hugo.   

Abstract

BACKGROUND: Although extracellular nucleotides have been shown to confer mitogenic effects in cultured rat mesangial cells through activation of purinergic P2 receptors (P2Y receptors), thus far the in vivo relevance of these findings is unclear. Virtually all cells and in particular the dense granules of platelets contain high levels of nucleotides that are released upon cell injury or platelet aggregation. In experimental mesangial proliferative glomerulonephritis in the rat (anti-Thy1 model), mesangiolysis and glomerular platelet aggregation are followed by a pronounced mesangial cell (MC) proliferative response leading to glomerular hypercellularity. Therefore, we examined the role of extracellular nucleotides and their corresponding receptors in nucleotide-stimulated cultured mesangial cells and in inflammatory glomerular disease using the P2 receptor antagonist PPADS.
METHODS: The effects of PPADS on nucleotide- or fetal calf serum (FCS)-stimulated proliferation of cultured MC were measured by cell counting and [3H]thymidine incorporation assay. After induction of the anti-Thy1 model, rats received injections of the P2-receptor antagonist PPADS at different doses (15, 30, 60 mg/kg BW). Proliferating mesangial and non-mesangial cells, mesangial cell activation, matrix accumulation, influx of inflammatory cells, mesangiolysis, microaneurysm formation, and renal functional parameters were assessed during anti-Thy1 disease. P2Y-mRNA and protein expression was assessed using RT-PCR and real time PCR, Northern blot analysis, in situ hybridization, and immunohistochemistry.
RESULTS: In cultured mesangial cells, PPADS inhibited nucleotide, but not FCS-stimulated proliferation in a dose-dependent manner. In the anti-Thy1 model, PPADS specifically and dose-dependently reduced early (day 3), but not late (day 8), glomerular mesangial cell proliferation as well as phenotypic activation of the mesangium and slightly matrix expansion. While no consistent effect was obtained in regard to the degree of mesangiolysis, influx of inflammatory cells, proteinuria or blood pressure, PPADS treatment increased serum creatinine and urea in anti-Thy1 rats. P2Y receptor expression (P2Y2 and P2Y6) was detected in cultured MC and isolated glomeruli, and demonstrated a transient marked increase during anti-Thy1 disease.
CONCLUSION: These data strongly suggest an in vivo role for extracellular nucleotides in mediating early MC proliferation after MC injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371966     DOI: 10.1046/j.1523-1755.2002.00621.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Extracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activity.

Authors:  S Klawitter; L P Hofmann; J Pfeilschifter; A Huwiler
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

Review 2.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

3.  Effects of diadenosine polyphosphates on glomerular volume.

Authors:  Miroslawa Szczepańska-Konkel; Maciej Jankowski; Anna Stiepanow-Trzeciak; Stefan Angielski
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Purine- and pyrimidine-induced responses and P2Y receptor characterization in the hamster proximal urethra.

Authors:  Christian Pinna; Rainer Glass; Gillian E Knight; Chiara Bolego; Lina Puglisi; Geoffrey Burnstock
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

5.  Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive rats.

Authors:  Martha Franco; Rocio Bautista; Edilia Tapia; Virgilia Soto; José Santamaría; Horacio Osorio; Ursino Pacheco; L Gabriela Sánchez-Lozada; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-02

Review 6.  The dark side of extracellular ATP in kidney diseases.

Authors:  Anna Solini; Vera Usuelli; Paolo Fiorina
Journal:  J Am Soc Nephrol       Date:  2014-12-01       Impact factor: 10.121

Review 7.  Extracellular Nucleotides and P2 Receptors in Renal Function.

Authors:  Volker Vallon; Robert Unwin; Edward W Inscho; Jens Leipziger; Bellamkonda K Kishore
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

8.  Cl- secretion in ATP-treated renal epithelial C7-MDCK cells is mediated by activation of P 2Y1 receptors, phospholipase A2 and protein kinase A.

Authors:  A Olga Akimova; Nathalie Bourcier; Sebastien Taurin; Richard A Bundey; Konrad Grygorczyk; Michael Gekle; Paul A Insel; Nickolai O Dulin; Sergei N Orlov
Journal:  J Physiol       Date:  2005-08-18       Impact factor: 5.182

9.  Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.

Authors:  Miguel L Graciano; Akira Nishiyama; Keith Jackson; Dale M Seth; Rudy M Ortiz; Minolfa C Prieto-Carrasquero; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2007-11-07

10.  Activation of P2Y1 and P2Y2 nucleotide receptors by adenosine 5'-triphosphate analogues augmented nerve-mediated relaxation of human corpus cavernosum.

Authors:  Serap Gur; Wayne J G Hellstrom
Journal:  Can Urol Assoc J       Date:  2009-08       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.